Analysis Metabolite Name Measured Value Units Cell Type Stimulation
Reversed phase NEGATIVE ION MODEGAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-193561Peak areaPAK Untreated
Reversed phase NEGATIVE ION MODEGAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-205444Peak areaPAK TNF-alpha
Reversed phase NEGATIVE ION MODEGAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-211678Peak areaHAHA TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEGAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-216020Peak areaBS4 Untreated
Reversed phase NEGATIVE ION MODEGAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-224970Peak areaHAHA Untreated
Reversed phase NEGATIVE ION MODEGAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-225677Peak areaPAK IL-17A
Reversed phase NEGATIVE ION MODEGAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-230306Peak areaHAHA TNF-alpha
Reversed phase NEGATIVE ION MODEGAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-231484Peak areaHAHA IL-17A
Reversed phase NEGATIVE ION MODEGAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-232360Peak areaPAK TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEGAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-251303Peak areaBS4 TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEGAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-274589Peak areaBS4 IFN-G
Reversed phase NEGATIVE ION MODEGAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-291262Peak areaBS4 IL-17A
Reversed phase NEGATIVE ION MODEGAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-291537Peak areaHAHA IFN-G
Reversed phase NEGATIVE ION MODEGAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-292761Peak areaBS4 TNF-alpha
Reversed phase NEGATIVE ION MODEGAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-530288Peak areaPAK IFN-G
Reversed phase POSITIVE ION MODEGAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+31049Peak areaHAHA TNF-alpha
Reversed phase POSITIVE ION MODEGAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+53037Peak areaPAK IFN-G
Reversed phase POSITIVE ION MODEGAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+Peak areaBS4 IFN-G
Reversed phase POSITIVE ION MODEGAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+Peak areaBS4 IL-17A
Reversed phase POSITIVE ION MODEGAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+Peak areaBS4 TNF-alpha
Reversed phase POSITIVE ION MODEGAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+Peak areaBS4 TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODEGAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+Peak areaBS4 Untreated
Reversed phase POSITIVE ION MODEGAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+Peak areaHAHA IFN-G
Reversed phase POSITIVE ION MODEGAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+Peak areaHAHA IL-17A
Reversed phase POSITIVE ION MODEGAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+Peak areaHAHA TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODEGAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+Peak areaHAHA Untreated
Reversed phase POSITIVE ION MODEGAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+Peak areaPAK IL-17A
Reversed phase POSITIVE ION MODEGAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+Peak areaPAK TNF-alpha
Reversed phase POSITIVE ION MODEGAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+Peak areaPAK TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODEGAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+Peak areaPAK Untreated

Return to search page
  logo